Stay updated on Dapagliflozin and Autonomic Function in T2D Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin and Autonomic Function in T2D Clinical Trial page.

Latest updates to the Dapagliflozin and Autonomic Function in T2D Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoChange DetectedAdded an explanatory note that publications shown are auto-filled from PubMed and may not pertain to the study. Updated the revision reference to v3.3.2 and revised the corresponding text accordingly.SummaryDifference0.1%

- Check21 days agoChange DetectedThe page removes a previously displayed government funding notice about NIH operations. No study content or outcomes are altered by this change.SummaryDifference0.4%

- Check35 days agoChange DetectedThe page has undergone a visual/layout redesign with no changes to core study content such as the title, description, outcomes, or eligibility criteria. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check63 days agoChange DetectedMajor update: announces a version upgrade to v3.2.0 and publicly states funding-related operational notices, including that transactions may not be processed until appropriations are enacted.SummaryDifference3%

- Check71 days agoChange DetectedShift the page focus from general public health topics to drug development and evaluation topics, with an updated version (v3.1.0) and removal of several public health topics (v3.0.2).SummaryDifference0.9%

- Check85 days agoChange DetectedUpdated the page from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.2%

Stay in the know with updates to Dapagliflozin and Autonomic Function in T2D Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin and Autonomic Function in T2D Clinical Trial page.